Sight Sciences Inc
(NAS:SGHT)
$
4.68
-0.42 (-8.24%)
Market Cap: 235.44 Mil
Enterprise Value: 172.91 Mil
PE Ratio: 0
PB Ratio: 2.51
GF Score: 75/100 Sight Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023 / 07:35PM GMT
Release Date Price:
$3.28
(-49.62%)
Kallum Titchmarsh
Morgan Stanley - Analyst
Perfect. Thank you very much, everyone. Really pleased today to have the team from Sight Sciences here. We got Paul Badawi, CEO; and Ali Bauerlein, CFO. Thank you so much.
Before we get started, we have to read you some fun disclosures here. So for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures.
Paul, obviously probably a bit dizzy today a little bit. Actually, yeah, maybe provide us some high-level overviews of the update you provided to us yesterday.
Paul Badawi
Sight Sciences, Inc. - Founder and CEO
On the LCDs?
Kallum Titchmarsh
Morgan Stanley - Analyst
We'll start on the LCDs, and then we can get over to [the matter] afterwards.
Questions & Answers
Paul Badawi
Sight Sciences, Inc. - Founder and CEO
Sure, yeah. So just quick
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot